EQUILLIUM, INC. Other Accrued Liabilities, Current
EQUILLIUM, INC. (EQ) had Other Accrued Liabilities, Current of $162.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $162.00K.
- 2026-03-31: Other Accrued Liabilities, Current $418.00K.
- 2025-12-31: Other Accrued Liabilities, Current $213.00K.
- 2025-09-30: Other Accrued Liabilities, Current $253.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $162.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $418.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $213.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $253.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $129.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $649.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $303.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $443.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $400.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $483.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $431.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $595.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $661.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $732.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $472.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $749.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $252.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $308.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $245.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $168.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $224.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $235.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $307.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $191.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $111.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $153.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $267.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $201.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $153.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $131.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $96.00K 10-K · filed 2020-03-26 | $96.41K 10-K · filed 2019-03-27 |
| 2018-09-30 | $586.28K 10-Q · filed 2018-11-15 | |
| 2017-12-31 | $632.00 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |